Acted for Resolute Health Corporation on its acquisition by The Kensington Private Equity Fund

On June 3, 2022, The Kensington Private Equity Fund (“Kensington”) announced its acquisition of Resolute Health Corporation Limited (“Resolute”), one of Canada’s leading healthcare services businesses specializing in the testing and treatment of obstructive sleep apnea (“OSA”).

Originally established as The Snore Shop in 2005 in Dartmouth, Nova Scotia by Dr. Neil Smith, the company became the largest provider of sleep therapy in Eastern Canada. Resolute was subsequently formed in 2017 when Dr. Smith entered into a partnership with Wade Dawe, through which Resolute expanded across Canada, becoming the largest independent provider of sleep therapy, and a leader in the diagnosis and treatment of OSA. At present, Resolute operates 72 clinics under 9 regional brands across 6 provinces and has provided testing and OSA therapy to over 250,000 patients.

Kensington, founded in 1996, is an employee-owned, high performing alternative investment firm with offices in Toronto, Vancouver and Calgary. Kensington's mission is to build great businesses, and in doing so, create top-performing investment solutions for its investors. Kensington has assets under management of $2.5 billion, managed across several active funds. 

Resolute’s founder, Dr. Neil Smith says, "Resolute is committed to helping patients improve their health and quality of life with tailored OSA treatment solutions. Partnering with Kensington will allow us to continue to create awareness around OSA and expand our geographic reach, providing more Canadians with access to best-in-class OSA testing and treatment."

In connection with the transaction, Kensington’s Managing Director, Kirk Hamilton, has joined Resolute’s board, alongside Kensington Principal, Jordan Bruce. Hamilton says of the transaction, "We are excited to partner with the Resolute team to continue to build and scale the company while providing the highest possible level of care to patients. With the increasing awareness and prevalence of OSA, we believe Resolute is well-positioned to service the demand for OSA testing and treatment across the country."